Navigation Links
AbbeyMoor Medical Receives Category I CPT(R) Code for The Spanner(TM) Prostatic Stent Procedure

PARKERS PRAIRIE, Minn., Oct. 14 /PRNewswire/ -- AbbeyMoor Medical Inc. announced today they have been granted a Category I CPT code by the American Medical Association (AMA) for The Spanner(TM) temporary prostatic stent insertion procedure. This important action, effective in January 2010, upgrades The Spanner from a Category III emerging technology procedure code to a Category I procedure code for established procedures. This major milestone for AbbeyMoor Medical will provide access to The Spanner for urologists and their patients across the United States.

The Spanner is the only FDA approved temporary prostatic stent. Patients who wear the stent have indicated their preference for The Spanner over catheterization.

"It is our goal to provide an improved quality of life for men suffering acute urinary retention," said John Reid, Co-Founder and CEO of AbbeyMoor Medical. "Receiving this Category I CPT code is an essential step in bringing this ingenious product to the national market. The code will assist physicians and their office staff in obtaining timely and accurate reimbursement for stent insertions in the office setting."

It is estimated that over 20 million American men suffer from symptoms of benign prostatic hyperplasia (BPH) with approximately 8 million men diagnosed with the condition. There are many options available for the treatment of BPH with medical therapy, traditional surgery, and an ever increasing number of minimally invasive treatment options. Many men choose one of several available minimally invasive office based treatments for their BPH to avoid the risks associated with surgery.

"We have several patients each month who benefit from The Spanner," said Douglas Chinn, urologist from Arcadia, CA. "We are excited to have this ingenious device now widely available to our patients and to have the ability to restore their quality of life," he added. Chinn is co-author of a recent article about the stent in Urology Times (July 2009): "How to manage BOO (bladder outlet obstruction) with temporary prostatic stenting."

The relative value units (RVUs) used to establish the payment amounts for The Spanner procedure will be published by the Centers for Medicare and Medicaid Services in the Federal Register later this fall. CPT code 53855 will replace Category III CPT code 0084T, effective January 1, 2010.

About CPT Coding

In addition to facilitating reimbursement in government programs such as Medicare and Medicaid, CPT codes are used by other insurance companies and government payers to describe health care services and procedures. In the development of new and revised Category I CPT codes the AMA requires:

  • That the service/procedure receive approval/clearance from the FDA
  • That the service/procedure is performed across the country in multiple locations
  • That many physicians perform the service/procedure
  • That the clinical efficacy for the service/procedure has been well established and documented.

More information about CPT codes and the process of establishing CPT codes is available at the AMA's website:

About The Spanner

The Spanner is a temporary prostatic stent designed to aid men who are experiencing difficulty in urination following a minimally invasive treatment for their BPH. Device placement can be safely performed in a physician's office and does not require cystoscopy or anesthesia. The Spanner is approved by the FDA for use up to 30 days in patients who have undergone minimally invasive treatment for benign prostatic hyperplasia following initial post treatment catheterization.

About AbbeyMoor Medical

AbbeyMoor Medical is a privately held company that develops and manufactures innovative medical devices focused on the management and treatment of male voiding dysfunction. The company's initial focus is on the development and commercialization of The Spanner.

For more information, please visit

SOURCE AbbeyMoor Medical Inc.

SOURCE AbbeyMoor Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Solta Medical Announces FDA 510(k) Clearance of New Fraxel re:store(R) Dual Laser System
2. Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available
3. Timm Medical Technologies and Ferring Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Prosed(R) DS
4. Cardiva Medical, Inc. Announces the Departure of its President and his Appointment as CEO of Innovative Energy, Inc.
5. Vibrant Exhibit Hall Features Innovative Medical Technology at AdvaMed 2009
6. Luminous Medical, Inc. Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor
7. Growing Supply Chain Complexity Increasing Impact on Medical Device Company Operations
8. Award-Winning Medical Technology From Germany
9. Cantel Medicals Crosstex Subsidiary Launches New Specially Treated Face Mask Effective Against H1N1 Influenza
10. ATS Medical Announces Receipt of CE Mark for the New ATS CryoMaze 10-S Probe
11. Sonitus Medical Technology Ranks #1 on Cleveland Clinics Top 10 Medical Innovations for 2010
Post Your Comments:
(Date:11/25/2015)... AVIV, Israel , November 25, 2015 ... (NASDAQ: KTOV ) (TASE: KTOV), a biopharmaceutical company ... simultaneous treatment of various clinical conditions, today announced the ... 3,158,900 American Depository Shares ( ADSs ), each representing ... purchase up to 3,158,900 ADSs. The ADSs and warrants ...
(Date:11/25/2015)... Nov. 25, 2015 Allergan plc (NYSE: ... and Rugen Therapeutics, a start-up  biotechnology company focused ... CNS disorders and funded by the F-Prime Biomedical ... entered into an exclusive collaboration to support the ... Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... TEL AVIV, Israel , November 25, 2015 /PRNewswire/ ... firms (the "New Investors"), pursuant to which BioLight and ... in BioLight,s IOPtima Ltd. subsidiary ("IOPtima") via a private ... global commercialization of its innovative IOPtimate™ system used in ... a regulatory approval pathway process for the IOPtimate™ system ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... Additional breast cancers found ... mammography, according to a study published online in the journal Radiology. Researchers said ... may necessitate a change in treatment. , Breast MRI is the most sensitive ...
(Date:11/25/2015)... ... November 25, 2015 , ... Medical Solutions, one of ... its stellar workplace culture with the company’s Cincinnati office being named a finalist ... office was named a finalist in Cincinnati Business Courier’s 13th annual Greater Cincinnati ...
(Date:11/25/2015)... ... , ... On November 10, 2015, Bohrer Brady, LLC filed a class and ... a home health care worker who provided companionship services for the elderly, ill or ... by Humana, Inc., Humana at Home, Inc., and SeniorBridge Family Companies (CT), Inc. since ...
(Date:11/25/2015)... ... , ... Dental professionals who would like to become more proficient on their ... Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held on December ... of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to announce ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... On November ... of Tri Lite’s personal heating products business. Cozy Products explains what this ... heaters that fit in well with the Cozy Products business model: to sell personal ...
Breaking Medicine News(10 mins):